Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03056001 |
|---|---|
| Brief Title: | Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma |
| First Submitted : | February 3, 2017 |
| First Submitted that Met QC Criteria : | February 15, 2017 |
| First Posted : | February 16, 2017 |
| Last Update Submitted that Met QC Criteria : | November 17, 2020 |
| Last Update Posted : | November 18, 2020 |